Cover European Journal of Microbiology and Immunology
European Journal of Microbiology and Immunology

Open Access

 

We are pleased to announce that the European Journal of Microbiology and Immunology has been selected for coverage in the Emerging Sources Citation Index (ESCI)

At the same time the journal is under evaluation by Clarivate Analytics to be accepted in the Science Citation Index Expanded(TM).

European Journal of Microbiology and Immunology is a Gold Open Access journal. It reports new discoveries in the field of medical microbiology and immunology of infection. Major focus on infections caused by pathogenic bacteria and parasites; molecular mechanisms of pathogenicity; host pathogen interaction; innate and adaptive immunity to infection and antimicrobial chemotherapy.

Topics that will be published are as follows: Reviews, original articles, results of prospective randomized trials, case studies, and PhD-theses summaries

Papers submitted are subject to single blind peer review performed by two independent reviewers. Papers accepted for publication by the Editorial Board are subject to editorial revision.

Articles are deposited on PubMedCentral following publication of an issue on the journal's official website.

Publication Ethics and Malpractice Statement of European Journal of Microbiology and Immunology: The journal follows the CODE OF CONDUCT AND BEST PRACTICE GUIDELINES FOR JOURNAL EDITORS and the COPE ETHICAL GUIDELINES FOR PEER REVIEWERS announced by the Committee on Publication Ethics.

Very low prevalence of Mansonella perstans-specific cell-free DNA in serum samples of Ghanaian HIV patients
DOI:
https://doi.org/10.1556/1886.2023.00028
Open access
Design and optimization of an improved qPCR assay for the detection of Histoplasma capsulatum
DOI:
https://doi.org/10.1556/1886.2023.00026
Open access
The impact of ketogenic diet on the onset and progression of multiple sclerosis
DOI:
https://doi.org/10.1556/1886.2023.00020
Open access
Not only for Christmas: Prophylactic oral application of trans-cinnamaldehyde alleviates acute murine campylobacteriosis
DOI:
https://doi.org/10.1556/1886.2023.00024
Open access
Performance of MassARRAY system for the detection of SARS-CoV-2 compared to real-time PCR
DOI:
https://doi.org/10.1556/1886.2023.00013
Pages:
1–5
Open access
Phytochemicals and micronutrients in suppressing infectivity caused by SARS-CoV-2 virions and seasonal coronavirus HCoV-229E in vivo
DOI:
https://doi.org/10.1556/1886.2023.00010
Pages:
6–14
Open access
Motility related gene expression of Campylobacter jejuni NCTC 11168 derived from high viscous media
DOI:
https://doi.org/10.1556/1886.2023.00006
Pages:
15–23
Open access
Case report: Disseminated gonococcal infection, a story of camouflage and deceit
DOI:
https://doi.org/10.1556/1886.2023.00004
Pages:
24–28
Open access
Adaptive immune system in severe COVID-19 patients in the first week of illness: A pilot study
DOI:
https://doi.org/10.1556/1886.2022.00022
Pages:
100–106
Open access
Human microbiota associated IL-10−/− mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota
DOI:
https://doi.org/10.1556/1886.2022.00024
Pages:
107–122
Open access
Contamination of dental unit water lines (DUWL) with Legionella pneumophila and Pseudomonas aeruginosa; A Middle East systematic review and meta-analysis
DOI:
https://doi.org/10.1556/1886.2022.00023
Pages:
93–99
Open access
Antibacterial effects of vanilla ingredients provide novel treatment options for infections with multidrug-resistant bacteria – A recent literature review
DOI:
https://doi.org/10.1556/1886.2022.00015
Pages:
53–62
Open access
Modulation of the intestinal microbiota impacts the efficacy of immunotherapy in cancer patients – A recent literature survey
DOI:
https://doi.org/10.1556/1886.2022.00017
Pages:
63–72
Open access
Colitis caused by Entamoeba histolytica identified by real-time-PCR and fluorescence in situ hybridization from formalin-fixed, paraffin-embedded tissue
DOI:
https://doi.org/10.1556/1886.2022.00016
Pages:
84–91
Open access
Campylobacter jejuni infection induces acute enterocolitis in IL-10-/- mice pretreated with ampicillin plus sulbactam
DOI:
https://doi.org/10.1556/1886.2022.00014
Pages:
73–83
Open access
Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment
DOI:
https://doi.org/10.1556/1886.2021.00021
Pages:
1–17
Open access
Immunomodulatory and antimicrobial effects of vitamin C
DOI:
https://doi.org/10.1556/1886.2019.00016
Pages:
73–79
Open access
Biodegradation of synthetic dyes of textile effluent by microorganisms: an environmentally and economically sustainable approach
DOI:
https://doi.org/10.1556/1886.2019.00018
Pages:
114–118
Open access
Cryptosporidium infection: epidemiology, pathogenesis, and differential diagnosis
DOI:
https://doi.org/10.1556/1886.2019.00019
Pages:
119–123
Open access
Determination of antimicrobial activity of some commercial fruit (apple, papaya, lemon and strawberry) against bacteria causing urinary tract infection
DOI:
https://doi.org/10.1556/1886.2018.00014
Pages:
95–99
Open access
Antibacterial effects of biologically active ingredients in hop provide promising options to fight infections by pathogens including multi-drug resistant bacteria
DOI:
https://doi.org/10.1556/1886.2022.00006
Pages:
22–30
Open access
The complement system: History, pathways, cascade and inhibitors
DOI:
https://doi.org/10.1556/eujmi.2.2012.2.2
Pages:
103–111
Open access
View license
Dissecting the interplay between intestinal microbiota and host immunity in health and disease: Lessons learned from germfree and gnotobiotic animal models
DOI:
https://doi.org/10.1556/1886.2016.00036
Pages:
253–271
Open access
Review: The risk of contracting anthrax from spore-contaminated soil – A military medical perspective
DOI:
https://doi.org/10.1556/1886.2020.00008
Pages:
29–63
Open access
Human adenovirus: Viral pathogen with increasing importance
DOI:
https://doi.org/10.1556/eujmi.4.2014.1.2
Pages:
26–33
Restricted access
Human adenovirus: Viral pathogen with increasing importance
DOI:
https://doi.org/10.1556/eujmi.4.2014.1.2
Pages:
26–33
Restricted access
The complement system: History, pathways, cascade and inhibitors
DOI:
https://doi.org/10.1556/eujmi.2.2012.2.2
Pages:
103–111
Open access
Molecular diagnosis of sepsis: New aspects and recent developments
DOI:
https://doi.org/10.1556/eujmi.4.2014.1.1
Pages:
1–25
Restricted access
Ageing and the immune system: focus on macrophages
DOI:
https://doi.org/10.1556/eujmi-d-14-00035
Pages:
14–24
Open access
Review and phylogenetic analysis of qac genes that reduce susceptibility to quaternary ammonium compounds in Staphylococcus species
DOI:
https://doi.org/10.1556/eujmi-d-14-00038
Pages:
44–61
Open access
Impact of enzymatic tissue disintegration on the level of surface molecule expression and immune cell function
DOI:
https://doi.org/10.1556/eujmi.2.2012.2.3
Pages:
112–120
Open access
Insights from 100 years of research with probiotic E. coli
DOI:
https://doi.org/10.1556/1886.2016.00029
Pages:
147–161
Open access
Dissecting the interplay between intestinal microbiota and host immunity in health and disease: Lessons learned from germfree and gnotobiotic animal models
DOI:
https://doi.org/10.1556/1886.2016.00036
Pages:
253–271
Open access
Monocytes in health and disease — Minireview
DOI:
https://doi.org/10.1556/eujmi.2.2012.2.1
Pages:
97–102
Open access
Gingipains from Porphyromonas gingivalis — complex domain structures confer diverse functions
DOI:
https://doi.org/10.1556/eujmi.1.2011.1.7
Pages:
41–58
Restricted access
  • Collapse
  • Expand
The author instruction is available in PDF.
Please, download the file from HERE.
 

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita

Editor(s)-in-Chief: Heimesaat, Markus M.

Vice Editor(s)-in-Chief: Fuchs, Anja

Editorial Board

Chair of the Editorial Board:
Jeffrey S. Buguliskis (Thomas Jefferson University, USA)

  • Jörn Albring (University of Münster, Germany)
  • Stefan Bereswill (Charité - University Medicine Berlin, Germany)
  • Dunja Bruder (University of Megdeburg, Germany)
  • Jan Buer (University of Duisburg, Germany)
  • Jeff Buguliskis (Thomas Jefferson University, USA)
  • Edit Buzas (Semmelweis University, Hungary)
  • Charles Collyer (University of Sydney, Australia)
  • Renato Damatta (UENF, Brazil)
  • Ivelina Damjanova (Semmelweis University, Hungary)
  • Maria Deli (Biological Research Center, HAS, Hungary)
  • Olgica Djurković-Djaković (University of Belgrade, Serbia)
  • Jean-Dennis Docquier (University of Siena, Italy)
  • Anna Erdei (Eötvös Loránd University, Hungary)
  • Zsuzsanna Fabry (University of Washington, USA)
  • Beniam Ghebremedhin (Witten/Herdecke University, Germany)
  • Nancy Guillen (Institute Pasteur, France)
  • Georgina L. Hold (University of Aberdeen, United Kingdom)
  • Ralf Ignatius (Charité - University Medicine Berlin, Germany)
  • Zsuzsanna Izsvak (MDC-Berlin, Germany)
  • Achim Kaasch (University of Cologne, Germany)
  • Tamás Laskay (University of Lübeck, Germany)
  • Oliver Liesenfeld (Roche, USA)
  • Shreemanta Parida (Vaccine Grand Challenge Program, India)
  • Matyas Sandor (University of Wisconsin, USA)
  • Ulrich Steinhoff (University of Marburg, Germany)
  • Michal Toborek (University of Miami, USA)
  • Mary Jo Wick (University of Gothenburg, Sweden)
  • Susanne A. Wolf (MDC-Berlin, Germany)

 

Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildikodunay@gmail.com

Indexing and Abstracting Services:

  • PubMed Central
  • Scopus
  • ESCI
  • CABI
  • CABELLS Journalytics

 

2022  
Web of Science  
Total Cites
WoS		 717
Journal Impact Factor 2.2
Rank by Impact Factor

n/a
Impact Factor
without
Journal Self Cites		 2.2
5 Year
Impact Factor		 2.8
Journal Citation Indicator 0.66
Rank by Journal Citation Indicator

Microbiology (Q2)
Scimago  
Scimago
H-index		 11
Scimago
Journal Rank		 0.614
Scimago Quartile Score Microbiology (Q3)
Microbiology (medical) (Q3)
Immunology and Allergy (Q3)
Immunology (Q3)
Scopus  
Scopus
Cite Score		 8.3
Scopus
CIte Score Rank		 Microbiology 33/163 (80th PCTL)
Microbiology (medical) 28/124 (77th PCTL)
Immunology and Allergy 63/211 (70th PCTL)
Immunology 69/217 (68th PCTL)
Scopus
SNIP		 1.221

 

2021  
Web of Science  
Total Cites
WoS		 790
Journal Impact Factor not applicable
Rank by Impact Factor not applicable
Impact Factor
without
Journal Self Cites		 not applicable
5 Year
Impact Factor		 not applicable
Journal Citation Indicator 0,64
Rank by Journal Citation Indicator Microbiology 81/157
Scimago  
Scimago
H-index		 not indexed
Scimago
Journal Rank		 not indexed
Scimago Quartile Score not indexed
Scopus  
Scopus
Cite Score		 not indexed
Scopus
CIte Score Rank		   not indexed
Scopus
SNIP		 not indexed

2020  
CrossRef Documents 23
WoS Cites 708
Wos H-index 27
Days from submission to acceptance 219
Days from acceptance to publication 176
Acceptance Rate 70%

2019  
WoS
Cites		 558
CrossRef
Documents		 24
Acceptance
Rate		 92%

 

European Journal of Microbiology and Immunology
Publication Model Gold Open Access
Submission Fee none
Article Processing Charge 600 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

European Journal of Microbiology and Immunology
Language English
Size A4
Year of
Foundation		 2011
Volumes
per Year		 1
Issues
per Year		 4
Founder Akadémiai Kiadó
Founder's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 2062-509X (Print)
ISSN 2062-8633 (Online)